Overall leadership of Jazz’s Global Commercial business.

Responsible for the development and operational execution of the commercial, market access and medical strategies for the region. Accountable for the region’s profit and loss and for the direct management or oversight of the internal and external resources required to deliver outstanding results, aligned to both corporate and regional business goals. Building and maintaining effective working relationships with corporate, country and non-commercial, functional leaders to ensure alignment between corporate strategic objectives and the tactical execution against these objectives at local/regional levels. Contributes to the development of the corporate/global business strategy. Member of the Executive Committee and Operations Executive Council. Participating in operating updates and leading discussions around key Europe & International agenda items with Board of Directors. Developing complimentary regional business strategies and executing on associated tactical initiatives, financial plans, staffing requirements required to drive and sustain commercial growth with the region. Evaluation of licensing and acquisition opportunities by collaborating with Corporate Development and Global New Product Planning to assess alignment with regional business objectives. Responsible for building and maintaining the infrastructure of people, processes and technology required to achieve Jazz’s commercial business objectives. This includes hiring, developing and retaining key talent. Ensuring alignment of corporate and regional cross functional resources including, but not limited to marketing, supply chain/manufacturing, medical affairs, regulatory affairs, clinical development.

Design, build and execute a compelling vision and strategy for the International Markets Region. Ensure IM operating model fully aligns with company strategy to develop ‘self-sufficient’ IM regional structure whilst operating within an efficient and robust governance structure. Manage and mitigate against the impact of LOE on key brands and prepare for new launches through the restructure of local operations. Attract and develop the best talent and create an environment where people can do their best work. Overall strategic and operational P&L accountability for LATAM, ASIAPAC (excl Japan), Russia, MENA, CEE, Turkey; ~$900M revenueKey Achievements Built new IM operating model and led business transformation across Turkey, CEE, CEA and North Africa maintaining business continuity, delivering ahead of internal expectations Built IM high performing regional team, attracting key talent internally and externally and defining clear accountabilities to facilitate fast, effective decision making  Created ‘Partner Markets Centre of Excellence’ to optimize business potential and leverage expertise across IM region  Established a highly effective P&MA governance model that effectively met the needs of the region to act with speed and flexibility whilst respecting the broader corporate governance requirements. Achieved 23 positive reimbursement outcomes since January 2019 Strengthened the compliance capability across the region and enhanced compliance structures in key geographies Led the development and execution of several key strategic projects including the localization of manufacturing in Russia; the liquidation of legal entities in Turkey, Morocco, NZ and UAE; market expansion and team build in Brazil  Successfully mitigated against the impact of loss of exclusivity on key brands, exceeding expectations in both 2018 (108% vs budget) and 2019 (114% vs budget YTD) through strategically resourcing and capturing opportunities.

Provided clear strategic vision and leadership of the region to define a sustainable strategy that delivers a clear winning focus on commercial priorities. Ensure strategy and priorities are aligned with global strategy and reflect an enterprise mindset. Couple this with a patient focused leadership consistent with our vision and values. Effectively manage transformation change to align operating models with emerging portfolio and priorities. Overall strategic and operational P&L accountability for Russia (& CIS), Turkey, Central Eastern Europe, Middle East Africa, Greece and Israel.

Overall strategic and operational P&L accountability for the performance of the UK and Ireland affiliate. Assigned interim responsibility for Nordics & Benelux alongside UK roleKey Achievements Grew UK/I total revenue from ~$80M to ~$300M in 5 years Strategically invested in organisational infrastructure development to support rapid growth and launch momentum increasing organisation from 50 to 140 people whilst growing margin to highest level in EU5 Successfully navigated complex reimbursement hurdles across the portfolio in all 5 jurisdictions  Transformed strength of in country leadership building high performing and aligned leadership team  Developed and communicated a vision for the affiliate which has led to a culture of high performance and engagement with top tier increases in 2 yrs Identified and built strategic organisational capabilities in medical and market access and key ‘license to operate’ functions Developed strong talent base with 14 employees progressing to roles in other jurisdictions in Celgene Established Celgene as the ‘place to be’ through media articles and awards, winning Company of the Year (twice) and numerous marketing and industry awards Personal achievements and impact recognized within industry with the PMEA ‘Industry Emerging Leader’ Award in 2011 Addressed pre-existing leadership issue in Benelux introducing flatter more effective organizational structure

UK Board Member with P&L accountability for specialist care, a business worth in excess of $500M. Direct responsibility and leadership of oncology, mental health, infection and vaccines business units as well as new product development and licensing.

Leadership of the cross functional team with direct line management of the marketing and sales teams incorporating, brand management, communications, advocacy, NHS development, market access and sales management. Overall responsibility for the breast franchise and the delivery of KPIs with P&L accountability.

Leadership of Strategic and Operational Planning Process incorporating organizational, brand and functional planning. Management of strategic and operational submissions to the centre. Leadership of and input into various cross functional teams in support of organizational objectives and transformational change projects

European input into global strategic planning for all pipeline & business development candidates including strategic positioning, project valuation & pre-launch planning. European responsibility for business development providing strategic analysis, modelling & deal structure recommendations on a Pan-European basis for a range of in-licensing opportunities. Started career as sales rep and gained full breadth of sales and marketing experience progressing through various sales and marketing leadership roles both in and above country.